Skip to main content
SpringerLink
Log in

Corticosteroid-related adverse outcomes costly in asthma

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The study was funded by AstraZeneca.

Reference

  • Voorham J, et al. Health care resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma. Allergy : 10 Jul 2018. Available from: URL: http://doi.org/10.1111/all.13556

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Corticosteroid-related adverse outcomes costly in asthma. Reactions Weekly 1712, 8 (2018). https://doi.org/10.1007/s40278-018-49297-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-49297-2

Search

Navigation